Written answers

Thursday, 9 June 2016

Department of Health

Medicinal Products Expenditure

Photo of Louise O'ReillyLouise O'Reilly (Dublin Fingal, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

137. To ask the Minister for Health the full year savings of immediately setting the ex-factory price for new pharmaceuticals, subject to patent protection, at the price in the lowest priced comparator member state of the European Union. [15121/16]

Photo of Louise O'ReillyLouise O'Reilly (Dublin Fingal, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

138. To ask the Minister for Health the full year savings that would be realised by immediately introducing generic substitutions for the 60 most commonly used off-patent medications, excluding anti-epileptic drugs, based on reference pricing at 70% below the branded equivalent, by cost and by volume. [15122/16]

Photo of Louise O'ReillyLouise O'Reilly (Dublin Fingal, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

139. To ask the Minister for Health the full year savings that would be realised from sourcing the 20 most expensive and the 20 most common on-patent pharmaceuticals from the European Union member state with the lowest cost for the drug, by parallel import. [15123/16]

Photo of Simon HarrisSimon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 137 to 139, inclusive, together.

It is not feasible to provide a robust estimate of savings from a reduction in the price of branded medicines to the lowest European Union level, as the price of each dosage form and strength would need to be assessed and compared with pricing data from all of the other member states. In addition, the HSE must consider continuity and security of supply in setting prices. Accordingly, the lowest EU price of an individual product may not always represent the best pricing point for Irish patients.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the primary care schemes, therefore the remaining matters have been referred to the HSE for attention and direct reply to you.

If you have not received a reply from the HSE within 15 working days, please contact my Private Office and they will follow up these matters with them.

Comments

No comments

Log in or join to post a public comment.